MENU
+Compare
PTCT
Stock ticker: NASDAQ
AS OF
Aug 12, 02:28 PM (EDT)
Price
$45.43
Change
+$2.13 (+4.92%)
Capitalization
3.44B

PTCT PTC Therapeutics Forecast, Technical & Fundamental Analysis

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders... Show more

Industry: #Biotechnology
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PTCT with price predictions
Aug 11, 2025

PTCT's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for PTCT moved into oversold territory on August 11, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for PTCT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The 10-day moving average for PTCT crossed bullishly above the 50-day moving average on August 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PTCT advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PTCT as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PTCT turned negative on August 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

PTCT moved below its 50-day moving average on August 08, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PTCT broke above its upper Bollinger Band on July 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PTCT entered a downward trend on July 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PTCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.507). P/E Ratio (6.437) is within average values for comparable stocks, (53.654). PTCT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.918). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (2.103) is also within normal values, averaging (288.769).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PTCT is expected to report earnings to rise 22.89% to -101 cents per share on October 23

PTC Therapeutics PTCT Stock Earnings Reports
Q3'25
Est.
$-1.02
Q2'25
Beat
by $0.23
Q1'25
Beat
by $11.07
Q4'24
Missed
by $0.06
Q3'24
Beat
by $0.12
The last earnings report on August 07 showed earnings per share of -82 cents, beating the estimate of -105 cents. With 121.96K shares outstanding, the current market capitalization sits at 3.44B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMQHX633.22N/A
N/A
Rydex Monthly Rbl NASDAQ-100® 2x Strt H
WOOSX18.11N/A
N/A
JPMorgan SMID Cap Equity R6
SGZFX62.11N/A
N/A
Saturna Growth Z
FIWBX15.00N/A
N/A
Fidelity Advisor Multi-Asset Income Z
CBFAX40.10-0.06
-0.15%
American Funds Global Balanced 529A

PTCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with ACLX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
-4.65%
ACLX - PTCT
45%
Loosely correlated
-1.99%
SYRE - PTCT
43%
Loosely correlated
+0.07%
XNCR - PTCT
42%
Loosely correlated
-3.18%
RXRX - PTCT
42%
Loosely correlated
-1.12%
IDYA - PTCT
41%
Loosely correlated
-1.13%
More